The sensitivity to paclitaxel treatment was improved in LIN28A high-expression T47D cells when LIN28A was knocked down; however, stable expression of LIN28 in breast cancer cells substantially reduced the sensitivity to paclitaxel treatment, leading to a considerable increase in paclitaxel IC50 values. Here, LIN28A is linked to breast carcinoma.